Lam's record gross margin reaffirms demand but supply constraints unchanged

What happened

Lam Research reported a record gross margin of 52.3% for the September 2026 quarter, fueled by strong AI-driven demand and a favorable product mix (Zacks cites 52.4%, a minor rounding discrepancy). The company's deferred revenue rose to $2.66 billion, signaling robust orders, but supply-chain and cleanroom constraints continue to delay customer acceptance and revenue recognition. Management has acknowledged that cleanroom space and component bottlenecks may persist through 2027, which tempers near-term upside despite the healthy demand environment. The recent Zacks article reiterates these dynamics but offers no new information beyond the margin figure, underscoring that the market's focus remains on execution rather than demand. Consequently, while the business is fundamentally strong, the stock's rich valuation at 32.8x P/E leaves little room for error if conversion does not improve.

Implication

The record gross margin demonstrates Lam's operating leverage and pricing power, but it does not resolve the key issue of delayed revenue recognition. With shares around $221, the valuation already assumes a normalization of bottlenecks and continued strong growth, limiting upside from current levels. A catalyst for a more bullish stance would be deferred revenue exceeding $2.9 billion and management softening its constraint commentary within the next two quarters. Conversely, if cleanroom and component issues persist into mid-2027, revenue conversion could disappoint, pushing the stock toward the bear case of $185. Therefore, investors should wait for concrete evidence of shipment acceleration or a pullback to the $195 entry zone before increasing exposure.

Thesis delta

No change. The Zacks article adds no new facts beyond confirming the record margin. The thesis remains intact: demand is strong, but supply constraints create timing risk. We reiterate WAIT with attractive entry near $195.